Key Details
- Board Meeting Date: Saturday, November 14, 2026
- Meeting Time: 04:00 PM
- Meeting Location: Corporate Office of the Company
Agenda Items
The Board will consider the following matters:
1. Consider and adopt the Unaudited Financial Statements (Standalone and Consolidated) for the Quarter and Half Year ended September 30, 2026
2. Consider the Limited Review Reports of the Statutory Auditor on Standalone and Consolidated Financial Statements for the Quarter and Half-Year ended September 30, 2026
3. Other Business items
Trading Window Update
In continuation of the earlier disclosure dated September 22, 2026 regarding closure of trading window effective October 01, 2026:
- Trading Window for dealing in the securities of the Company shall open after 48 hours of declaration of Unaudited Financial Results for the Quarter and Half Year ended September 30, 2026
- This applies to all designated persons, their immediate relatives and all connected persons covered under the code
Additional Information
- This intimation is being uploaded on the Company website: www.gennexlab.com
- Company CIN: L24230TG1990PLC011168
- Signed by Dinesh Kumar Kejriwal, Company Secretary & Compliance Officer (Membership #A19293)